AzTrials
AzTrials

Craniocerebral TraumaTIMELYNCT06632587

Timing Impact of Early vs. Late Cranioplasty on Hemicraniectomy Outcomes

A study testing Early cranioplasty and Standard-of-care cranioplasty in people with Craniocerebral Trauma and Stroke, run by Thomas Jefferson University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective, randomized study aims to comprehensively evaluate the impact of cranioplasty timing on postoperative complications and long-term functional outcomes following decompressive hemicraniectomy (DHC). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Early cranioplasty and Standard-of-care cranioplasty
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
44 participants
Where
1 siteUnited States
Study dates
1 Sep 2024to 1 Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adults of age greater than or equal to 18 years at the time of acute traumatic injury or source of increased intracranial pressure secondary to stroke or intracranial hemorrhage necessitating decompressive hemicraniectomy (DHC)
  • Patient's cranial flap fulfills Craniectomy Contour Class A or B after 4 weeks postoperatively (doi:10.1227/ons.0000000000000689)
  • Medically optimized for general anesthesia/surgery

Who cannot join

  • Active systemic infection in weeks 6-8 post-DHC leading up to cranioplasty (e.g. pneumonia, urinary tract infection, soft tissue infection, bacteremia)
  • Cranial infection in the post-DHC period
  • Patient deemed not appropriate for early cranioplasty by attending neurosurgeon
  • Patient mortality prior to 8 weeks post-injury ("injury" defined as "acute traumatic injury or source of increased intracranial pressure causing brain injury secondary to stroke or intracranial hemorrhage")

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • Thomas Jefferson University Hospitals

    Philadelphia, Pennsylvania, 19107

    Pious Patel, MD, (215) 955-7000

    Recruiting

Other trials in United States

About this study

Official title: Comparing Outcomes Between Early and Standard-of-care Delayed Cranioplasty After Decompressive Hemicraniectomy

This prospective, randomized study aims to comprehensively evaluate the impact of cranioplasty timing on postoperative complications and long-term functional outcomes following decompressive hemicraniectomy (DHC). The primary endpoint focuses on comparing the rates of various postoperative complications, including infection, seizures, return to the operating room, and the need for ventriculoperitoneal shunting, between patients undergoing standard of care cranioplasty (>3 months after DHC) and those receiving early cranioplasty (within 8 weeks).

Read the detailed description

This prospective, randomized study aims to comprehensively evaluate the impact of cranioplasty timing on postoperative complications and long-term functional outcomes following decompressive hemicraniectomy (DHC). The primary endpoint focuses on comparing the rates of various postoperative complications, including infection, seizures, return to the operating room, and the need for ventriculoperitoneal shunting, between patients undergoing standard of care cranioplasty (>3 months after DHC) and those receiving early cranioplasty (within 8 weeks).

The primary endpoint involves a comprehensive evaluation of long-term functional outcomes at 6 months post-injury ("injury" defined as "acute traumatic injury or source of increased intracranial pressure secondary to stroke or intracranial hemorrhage"). This assessment aims to determine whether the timing of cranioplasty influences patients' neurological recovery, cognitive function, and overall quality of life. By comparing the outcomes of patients who undergo standard of care cranioplasty with those who undergo early cranioplasty, the study seeks to provide valuable insights into the potential benefits of the latter approach.

The findings of this research hold the potential to guide clinical practice and inform decision-making for patients who have undergone DHC. By considering a range of complications and incorporating a robust statistical framework, the study contributes to a more nuanced understanding of the advantages and disadvantages associated with different cranioplasty timing strategies.

Being tested
Early cranioplasty, Standard-of-care cranioplasty
Keywords
Decompressive hemicraniectomy, cranioplasty, cranial trauma, stroke, intracranial hemorrhage, intracerebral hemorrhage, neurosurgery
Medical subject headings
Craniocerebral Trauma, Stroke, Intracranial Hemorrhages, Cerebral Hemorrhage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early cranioplastyProcedure or surgery

    Cranioplasty is the surgical procedure to restore the skull after a decompressive hemicraniectomy. The latter procedure is employed as a life-saving measure to relieve intracranial pressure in patients with acute cranial injuries. Early cranioplasty is defined as being performed within 8 weeks following the decompressive hemicraniectomy.

  • Standard-of-care cranioplastyProcedure or surgery

    Cranioplasty is the surgical procedure to restore the skull after a decompressive hemicraniectomy. The latter procedure is employed as a life-saving measure to relieve intracranial pressure in patients with acute cranial injuries. Standard-of-care cranioplasty is defined as being performed after 3 months following the decompressive hemicraniectomy.

Study groups in NCT06632587
Study groupRoleWhat they receive
Early cranioplastyActive comparatorCranioplasty procedure performed prior to 8 weeks following the initial decompressive hemicraniectomy.
Receives: Procedure: Early cranioplasty
Standard-of-care cranioplastyPlacebo comparatorCranioplasty procedure performed after 3 months following the initial decompressive hemicraniectomy.
Receives: Procedure: Standard-of-care cranioplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional outcome at 6 months post-decompressive hemicraniectomy

    modified Rankin scale outcome at 6 months post-decompressive hemicraniectomy

    Measured: 6 months post-decompressive hemicraniectomy

  2. Functional outcome at 12 months post-decompressive hemicraniectomy

    modified Rankin scale outcome at 12 months post-decompressive hemicraniectomy

    Measured: 12 months post-decompressive hemicraniectomy

Secondary outcomes (7)
  1. Post-cranioplasty seizure

    Post-cranioplasty seizure occurrence, diagnosed clinically or on EEG

    Measured: 1 month post-cranioplasty

  2. Post-cranioplasty hydrocephalus

    Post-cranioplasty hydrocephalus or need for cerebrospinal fluid diversion

    Measured: 1 month post-cranioplasty

  3. Post-cranioplasty return to operating room

    All-cause return to operating room after cranioplasty

    Measured: 1 month post-cranioplasty

  4. Post-cranioplasty infection

    Surgical site or intracranial infection after cranioplasty

    Measured: 12 months post-cranioplasty

  5. Post-cranioplasty disposition

    Post-cranioplasty disposition (home, acute rehab, subacute rehab, death)

    Measured: 12 months post-cranioplasty

  6. Post-cranioplasty length of hospital stay

    Post-cranioplasty length of hospital stay

    Measured: 12 months post-cranioplasty

  7. Readmission within 30 days post-cranioplasty

    Readmission within 30 days post-cranioplasty

    Measured: 30 days post-cranioplasty

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Oct 2024
  2. Study start1 Sep 2024
  3. Primary completion1 Sep 2027 (estimated)
  4. Study completion1 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
44 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06632587
Sponsor's protocol ID
iRISID-2024-3103
Acronym
TIMELY
Status last verified
Oct 2024
First submitted
26 Sep 2024
Last updated
23 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Patel PD, Khanna O, Gooch MR, Glener SR, Mouchtouris N, Momin AA, Sioutas G, Amllay A, Barsouk A, El Naamani K, Yudkoff C, Wyler DA, Jallo JI, Tjoumakaris S, Jabbour PM, Harrop JS. Clinical Outcomes After Ultra-Early Cranioplasty Using Craniectomy Contour Classification as a Patient Selection Criterion. Oper Neurosurg. 2023 Jul 1;25(1):72-80. doi: 10.1227/ons.0000000000000689. Epub 2023 May 5.

    PubMed 37166197
  • Malcolm JG, Rindler RS, Chu JK, Chokshi F, Grossberg JA, Pradilla G, Ahmad FU. Early Cranioplasty is Associated with Greater Neurological Improvement: A Systematic Review and Meta-Analysis. Neurosurgery. 2018 Mar 1;82(3):278-288. doi: 10.1093/neuros/nyx182.

    PubMed 28419358
  • Eaton JC, Greil ME, Nistal D, Caldwell DJ, Robinson E, Aljuboori Z, Temkin N, Bonow RH, Chesnut RM. Complications associated with early cranioplasty for patients with traumatic brain injury: a 25-year single-center analysis. J Neurosurg. 2022 Jan 21;137(3):776-781. doi: 10.3171/2021.11.JNS211557. Print 2022 Sep 1.

    PubMed 35061995
  • Sethi A, Chee K, Kaakani A, Beauchamp K, Kang J. Ultra-Early Cranioplasty versus Conventional Cranioplasty: A Retrospective Cohort Study at an Academic Level 1 Trauma Center. Neurotrauma Rep. 2022 Aug 1;3(1):286-291. doi: 10.1089/neur.2022.0026. eCollection 2022.

    PubMed 36060455

Questions about this trial

What is this clinical trial studying?

A study testing Early cranioplasty and Standard-of-care cranioplasty in people with Craniocerebral Trauma and Stroke, run by Thomas Jefferson University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Pious Patel, MD ((215) 955-7000, pious.patel@jefferson.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional outcome at 6 months post-decompressive hemicraniectomy (time frame: 6 months post-decompressive hemicraniectomy). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06632587, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in